stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Price to free cash flow
As of 5 November 2026, iRhythm Holdings, Inc. (IRTC) trades at a price to free cash flow of 584×. Over the past ten years it has ranged from 0.0× (March 2025) to 601× (November 2026); the current reading is higher than 100% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 165× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 510× | 407.73% |
| Jun 2026 | 100× | (50.93%) |
| Mar 2026 | 205× | 24.36% |
| Dec 2025 | 165× | (3.61%) |
| 40 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| HAE Haemonetics Corporation compare | 18.1× |
| UFPT UFP Technologies, Inc. compare | 37.5× |
| LIVN LivaNova PLC compare | 38.0× |
| NEOG Neogen Corporation compare | 51.0× |
| ITGR Integer Holdings Corporation compare | 53.3× |
| TMDX TransMedics Group, Inc. compare | 53.5× |
| TXG 10x Genomics compare | 63.3× |
| AXGN AxoGen, Inc. compare | 134× |
| IRTC iRhythm Holdings, Inc. | 584× |
| Medical Devices industry median | 28.8× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on IRTC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement